WASHINGTON, D.C. (February 26, 2024) – Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:
- Morehouse School of Medicine and Grady Health System in Atlanta, Georgia;
- Yale School of Medicine and Medical University of South Carolina in Florence, South Carolina;
- Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, Texas Southern University in Houston and University of Texas Medical Branch in Galveston, Texas; and
- Vanderbilt University Medical Center and Meharry Medical College in Nashville, Tennessee.
The selection of these sites is part of EQBMED’s plan to identify an initial 10 community-facing clinical trial sites in historically underrepresented communities of color across the country.
EQBMED’s multi-stakeholder model employs a holistic approach that considers the baseline capabilities of each site, allowing EQBMED to focus on creating opportunities for communities of color to participate and stay true to the program’s mission to promote clinical trial access and education.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.